FDA approves sotatercept for treatment of pulmonary arterial hypertension in adults Dr. Kamal Kant Kohli28 March 2024 7:30 PM ISTThe US Food and Drug Administration has approved sotatercept (Winrevair) for treatment of pulmonary arterial hypertension (PAH) in adults....
Merck gets USFDA nod for WINREVAIR (sotatercept-csrk) for adults with pulmonary arterial hypertension Ruchika Sharma27 March 2024 11:51 AM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced that the U.S. Food and Drug Administration (FDA) has approved...
Single tablet combo of macitentan and tadalafil receives US FDA approval for pulmonary artery hypertension Dr. Kamal Kant Kohli25 March 2024 3:30 AM ISTUSA: A single-tablet combination of macitentan and tadalafil (Opsynvi) has received approval from the US Food and Drug Administration (FDA) as the...
JnJ gets USFDA nod for Opsynvi for chronic treatment of adults with pulmonary arterial hypertension Ruchika Sharma23 March 2024 12:23 PM ISTRaritan: Johnson & Johnson has announced that the U.S. Food and Drug Administration (FDA) has approved OPSYNVI - a single-tablet combination...
Cardiosphere-derived stem cells effective for treatment of pulmonary arterial hypertension Dr. Kamal Kant Kohli22 Dec 2023 7:00 PM ISTUSA: Intravenous cardio-sphere-derived cells (CDCs) are safe in both the short and long term in subjects with pulmonary arterial hypertension (PAH),...
ECG useful in identifying pulmonary hypertension in patients with severe tricuspid regurgitation Medha Baranwal9 Dec 2023 11:00 AM ISTPoland: ECG analysis can predict pulmonary arterial hypertension (PAH) in patients with severe tricuspid regurgitation (TR), according to a new study...
Granules India subsidiary bags USFDA nod for Sildenafil for Oral Suspension Ruchika Sharma4 Dec 2023 1:30 PM ISTSildenafil for Oral Suspension is indicated for the treatment of pulmonary arterial hypertension (PAH) (World Health Organization [WHO] Group I) in...
Merck Sotatercept for pulmonary arterial hypertension gets USFDA priority review Ruchika Sharma30 Sept 2023 11:00 AM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced that the U.S. Food and Drug Administration (FDA) has accepted for...
Merck presents new analyses from Sotatercept studies for adults with pulmonary arterial hypertension Ruchika Sharma13 Sept 2023 1:30 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced new analyses from studies of sotatercept, Merck’s novel...
MSN Lab gets CDSCO Panel Nod To Manufacture, Market Combi kit for Macitentan 10mg plus Tadalafil 20mg Dr. Divya Colin9 Sept 2023 6:00 PM ISTNew Delhi: Granting approval for Phase III clinical trial and bioequivalence (BE) study wavier, the Subject Expert Committee (SEC) functional under...
MSN Laboratories Gets CDSCO Panel Nod To Manufacture, Market Selexipag for Injection Dr. Divya Colin20 July 2023 6:00 PM ISTNew Delhi: The drug major MSN Laboratories has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Zydus Lifesciences bags USFDA nod for pulmonary arterial hypertension drug Tadalafil Ruchika Sharma8 Jun 2023 11:32 AM ISTThe product will be manufactured at the group's formulation manufacturing facility in Moraiya, Ahmedabad, India.
